FDA Inspection 990270 — NewYork-Presbyterian/Weill Cornell Medical Center
The FDA completed an inspection of NewYork-Presbyterian/Weill Cornell Medical Center on Oct 28, 2016 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 28, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)